VANCOUVER, British Columbia, March 02, 2023 (GLOBE NEWSWIRE) — THC BioMed Intl (CSE:THC) (OTCQB:THCBF) (FSE:TFHD), one of Canada’s oldest licensed producers of medical and recreational cannabis, has started sales and export of its patented Clone Shipper containers to Asia. The innovative Clone Shipper container’s patented design enables plants, especially clones or young plants, to be shipped safely while nurturing the plant in the growing process.
A Media Snippet accompanying this announcement is available by clicking on the image or link below:
For more information, please view the InvestmentPitch Media video which provides additional information about this news and the company. The video is available for viewing on “InvestmentPitch” and on “YouTube”. If these links are not enabled, please visit www.InvestmentPitch.com and enter “THC BioMed” in the search box.
The reusable container, built to last for multiple shipments, comes with a new opaque lid and an LED light, designed to last for a minimum of 100 hours. The virtually indestructible container is manufactured in North America and can be purchased online at www.CloneShipper.com or in Asia through THC BioMed Thailand.
John Miller, President and CEO, stated: “THC BioMed is incredibly pleased to have entered the Asian medical cannabis market while it is still in its infancy. THC BioMed anticipates massive growth in the Asian medical cannabis sector and is well-positioned to embrace what has the potential to be the largest medical cannabis market in the world.”
With its cultivation and production based in Kelowna, B.C., including a proprietary extraction system, THC was first licensed to deal with cannabis in 2013 under a Health Canada Section 56 exemption under the Controlled Drugs and Substances Act and has been a Licensed Producer under the current regime since 2016.
THC BioMed, a small batch Licensed Producer passionate about using organic and sustainable growing methods, operates in a sophisticated complex of indoor growing space in small rooms with the desired light, temperature, and humidity. The process is mainly done by hand, from watering, cannabis harvesting, to flower trimming, allowing the company to focus on high-quality, high-potency products including dry flower, edibles, beverages, pre-rolls along with a number of genetic strains which it sells to Canada’s medical and recreational cannabis markets.
The shares are currently trading at $0.075. For more information, please visit www.THCbiomed.com, contact John Miller, President & CEO, at 1-844-842-6337 or email info@THCbiomed.com.
Disclaimer
The information in this InvestmentPitch Media Ltd video is for the viewers information only. THC BioMed has paid a fee not exceeding $2,000 in cash to have its current news release produced in video format. The corporate information is based on information that is publicly available. Any information provided by InvestmentPitch Media Ltd, through its media services is not to be construed as a recommendation or suggestion or offer to buy or sell securities but is provided solely as an informational media service. InvestmentPitch Media Ltd makes no warranties or undertakings as to the accuracy or completeness of this information. All due diligence should be done by the viewer or their financial advisor. Investing in securities is speculative and carries risk.
About InvestmentPitch Media
InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.
